Paikkatietoaineistosta puuttuvan datan mallintaminen Markovin satunnaiskentillä

Sisältää lisäksi 14 liitesivu

Sepelvaltimotauti ja tyypin 2 diabetes - kohtalokas yhdistelmä

Diabeteksen tunnistaminen sydänsairauden ilmene­misen jälkeen on edelleen ajankohtaist

Voiko sydänperäistä äkkikuolemaa ennustaa tai estää?

PDF-linkki ei toiminnassa. English summaryPeer reviewe

Are T-Inversions in Chest Leads Always Benign?

Non peer reviewe

Sydämentahdistimet - millaisia, keille ja mitä kliinikon tulee huomioida?

Vertaisarvioitu. English summary.Tahdistinlaitteita käytetään sydämen hidaslyöntisyyden, kammioperäisten rytmihäiriöiden ja sydämen vaikean vajaatoiminnan hoidossa. Tahdistin ohjelmoidaan yksilöllisesti, jotta hoito olisi tehokasta ja turvallista. Hidaslyöntisyyden tahdistuksessa tavoitteena on korjata sydämen johtoratavaurion aiheuttama haitta ja palauttaa sydämen normaali sähköinen aktivaatiojärjestys välttäen aiheetonta kammiotahdistusta. Rytmihäiriötahdistin pysäyttää pitkäkestoisen kammiotakykardian tai kammiovärinän. Vajaatoiminnan tahdistinhoidossa pyritään parantamaan vasemman kammion toimintaa optimoimalla vasemman kammion täyttö sekä yhtäaikaistamalla kammioseinämien supistus biventrikulaarisella tahdistuksella. Osassa vajaatoimintatahdistimista on mahdollisuus myös rytmihäiriötahdistinhoitoon. Hisin kimpun tahdistus mahdollistaa fysiologisen kammioiden aktivaation johtoratajärjestelmän kautta ilman oikean kammion tahdistukseen liittyviä haittoja. Johdottomalla tahdistimella ja ihonalaisella rytmihäiriötahdistimella voidaan välttää tahdistinhoitoon liittyviä johto-ongelmia ja infektiokomplikaatioita.Peer reviewe

B-type natriuretic peptide ability to predict mortality after transcatheter aortic valve replacement

Peer reviewe

Waveform prototype-based feature learning for automatic detection of the early repolarization pattern in ECG signals

Objective: Our aim was to develop an automated detection method, for prescreening purposes, of early repolarization (ER) pattern with slur/notch configuration in electrocardiogram (ECG) signals using a waveform prototype-based feature vector for supervised classification. Approach: The feature vectors consist of fragments of the ECG signal where the ER pattern is located, instead of abstract descriptive variables of ECG waveforms. The tested classifiers included linear discriminant analysis, k-nearest neighbor algorithm, and support vector machine (SVM). Main results: SVM showed the best performance in Friedman tests in our test data including 5676 subjects representing 45408 leads. Accuracies of the different classifiers showed results well over 90%, indicating that the waveform prototype-based feature vector is an effective representation of the differences between ECG signals with and without the ER pattern. The accuracy of inferior ER was 92.74% and 92.21% for lateral ER. The sensitivity achieved was 91.80% and specificity was 92.73%. Significance: The algorithm presented here showed good performance results, indicating that it could be used as a prescreening tool of ER, and it provides an additional identification of critical cases based on the distances to the classifier decision boundary, which are close to the 0.1 mV threshold and are difficult to label.Peer reviewe

GSK3β Serine 389 Phosphorylation Modulates Cardiomyocyte Hypertrophy and Ischemic Injury

Prior studies show that glycogen synthase kinase 3β (GSK3β) contributes to cardiac ischemic injury and cardiac hypertrophy. GSK3β is constitutionally active and phosphorylation of GSK3β at serine 9 (S9) inactivates the kinase and promotes cellular growth. GSK3β is also phosphorylated at serine 389 (S389), but the significance of this phosphorylation in the heart is not known. We analyzed GSK3β S389 phosphorylation in diseased hearts and utilized overexpression of GSK3β carrying ser→ala mutations at S9 (S9A) and S389 (S389A) to study the biological function of constitutively active GSK3β in primary cardiomyocytes. We found that phosphorylation of GSK3β at S389 was increased in left ventricular samples from patients with dilated cardiomyopathy and ischemic cardiomyopathy, and in hearts of mice subjected to thoracic aortic constriction. Overexpression of either GSK3β S9A or S389A reduced the viability of cardiomyocytes subjected to hypoxia–reoxygenation. Overexpression of double GSK3β mutant (S9A/S389A) further reduced cardiomyocyte viability. Determination of protein synthesis showed that overexpression of GSK3β S389A or GSK3β S9A/S389A increased both basal and agonist-induced cardiomyocyte growth. Mechanistically, GSK3β S389A mutation was associated with activation of mTOR complex 1 signaling. In conclusion, our data suggest that phosphorylation of GSK3β at S389 enhances cardiomyocyte survival and protects from cardiomyocyte hypertrophy

GSK3β Serine 389 Phosphorylation Modulates Cardiomyocyte Hypertrophy and Ischemic Injury

Prior studies show that glycogen synthase kinase 3β (GSK3β) contributes to cardiac ischemic injury and cardiac hypertrophy. GSK3β is constitutionally active and phosphorylation of GSK3β at serine 9 (S9) inactivates the kinase and promotes cellular growth. GSK3β is also phosphorylated at serine 389 (S389), but the significance of this phosphorylation in the heart is not known. We analyzed GSK3β S389 phosphorylation in diseased hearts and utilized overexpression of GSK3β carrying ser→ala mutations at S9 (S9A) and S389 (S389A) to study the biological function of constitutively active GSK3β in primary cardiomyocytes. We found that phosphorylation of GSK3β at S389 was increased in left ventricular samples from patients with dilated cardiomyopathy and ischemic cardiomyopathy, and in hearts of mice subjected to thoracic aortic constriction. Overexpression of either GSK3β S9A or S389A reduced the viability of cardiomyocytes subjected to hypoxia–reoxygenation. Overexpression of double GSK3β mutant (S9A/S389A) further reduced cardiomyocyte viability. Determination of protein synthesis showed that overexpression of GSK3β S389A or GSK3β S9A/S389A increased both basal and agonist-induced cardiomyocyte growth. Mechanistically, GSK3β S389A mutation was associated with activation of mTOR complex 1 signaling. In conclusion, our data suggest that phosphorylation of GSK3β at S389 enhances cardiomyocyte survival and protects from cardiomyocyte hypertrophy

Waveform prototype-based feature learning for automatic detection of the early repolarization pattern in ECG signals

Objective: Our aim was to develop an automated detection method, for prescreening purposes, of early repolarization (ER) pattern with slur/notch configuration in electrocardiogram (ECG) signals using a waveform prototype-based feature vector for supervised classification. Approach: The feature vectors consist of fragments of the ECG signal where the ER pattern is located, instead of abstract descriptive variables of ECG waveforms. The tested classifiers included linear discriminant analysis, k-nearest neighbor algorithm, and support vector machine (SVM). Main results: SVM showed the best performance in Friedman tests in our test data including 5676 subjects representing 45408 leads. Accuracies of the different classifiers showed results well over 90%, indicating that the waveform prototype-based feature vector is an effective representation of the differences between ECG signals with and without the ER pattern. The accuracy of inferior ER was 92.74% and 92.21% for lateral ER. The sensitivity achieved was 91.80% and specificity was 92.73%. Significance: The algorithm presented here showed good performance results, indicating that it could be used as a prescreening tool of ER, and it provides an additional identification of critical cases based on the distances to the classifier decision boundary, which are close to the 0.1 mV threshold and are difficult to label.Peer reviewe